Construction of Saccharopolyspora erythraea A226-ΔeryCⅢ mutant and identification of its product

XU Xiao-juan,HUANG Xun-duan,ZHAO Wei,GUO Jin-hua,CHEN Hui-peng,CAO Cheng,ZHANG Bu-chang
2010-01-01
Abstract:Objective To construct a glycosyltransferase EryCⅢ inactivated mutant of Saccharopolyspora erythraea in order to study how to modify sugar structures and synthesize novel derivatives of erythromycin.Methods The mutant DNA fragment of eryCⅢ gene after deletion of a 130 bp in key site was amplified by PCR and cloned into the homologous recombinant vector pWHM3 to form pWHM3-ΔeryCⅢ,and then pWHM3-ΔeryCⅢ was transferred into Sac.erythraea A226.After two rounds of homologous recombination,one mutant lacking EryCⅢ activity named A226-ΔeryCⅢ was screened out.Bioassay test,TLC and MS were used to analyze the fermentation products of A226-ΔeryCⅢ,and complementation test was used for verification.Results Sequence analysis of Sac.erythraea mutant A226-ΔeryCⅢ showed that the corresponding 130 bp length fragment in eryCⅢ gene was deleted,and bioassay test indicated that the fermentation product of A226-ΔeryCⅢ did not have the ability to inhibit Bacillus subtilis.The results of TLC and MS showed that there was 3-L-mycarose erythronolide B(MEB)accumulated in the mutant,but no erythromycins.The complementation test suggested that introduction of eryCⅢ gene into A226-ΔeryCⅢ restored the ability to produce erythromycins.Conclusion The Sac.erythraea mutant A226-ΔeryCⅢ with glycosyltransferase EryCⅢ inactivated is successfully constructed,and it sheds light on synthesis of erythromycin derivatives through combinatorial biosynthesis.
What problem does this paper attempt to address?